Skip to main content
logo
Immunovia AB (publ) (STO:IMMNOV)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.1622
+0.0006 (0.37%)
Aug 12, 2026, 4:55 PM CET

Immunovia AB Financials Overview

Millions SEK. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1.290.751.691.81.20.96
Revenue Growth
15.66%-55.61%-5.99%49.67%25.94%-3.04%
Gross Profit
0.760.621.69-4.88-3.01-2.58
Operating Income
-82.74-80.39-109.41-296.46-191.15-166.63
Net Income
-88.33-145.92-76.54-309.44-168.09-155.97
Earnings Per Share
-10.09-0.42-0.93-7.95-7.43-6.89
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
34.977.4625.3276.79106.04287.41
Total Debt
3.270.860.6810.2737.5733.26
Net Cash (Debt)
31.6376.624.6466.5268.47254.14
Net Cash Growth
9.81%210.91%-62.96%-2.84%-73.06%-41.62%
Net Cash Per Share
0.070.220.301.713.0311.23

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-77.35-78.4-96.75-147.06-175.58-152.65
Capital Expenditures
0000-1.26-3.1
Free Cash Flow
-77.35-78.4-96.75-147.06-176.84-155.75
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
59.46%81.91%100.00%-270.81%-249.75%-269.56%
Operating Margin
-6438.83%-10689.50%-6458.74%-16451.70%-15876.20%-17429.70%
Pretax Margin
-5599.84%-19403.59%-4518.36%-17171.98%-13961.13%-16314.44%
Profit Margin
-6874.24%-19403.60%-4518.36%-17172.00%-13961.10%-16314.40%
FCF Margin
-6019.53%-10425.50%-5711.51%-8160.77%-14687.50%-16291.70%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
89.252.030.430.171.776.36